Balancing Bleeding and Ischemic Risk: Dual Antiplatelet Therapy in a 90-Year-Old Man With Myocardial Infarction and...

Area of Science:

• Cardiology
• Gastroenterology
• Geriatrics

Background:

• Managing myocardial infarction (MI) in patients with active gastrointestinal (GI) bleeding poses significant clinical challenges.
• Balancing antithrombotic therapy against bleeding risk is critical, especially distinguishing Type 1 from Type 2 MI.
• Older adults present unique complexities in managing these comorbid conditions.

Purpose of the Study:

• To present a case of MI in a patient with active GI bleeding.
• To illustrate the challenges in managing antiplatelet therapy in this high-risk population.
• To highlight the importance of individualized treatment strategies.

Main Methods:

• Case report of a 90-year-old male with MI, severe anemia, and active GI bleeding.
• Evaluation of MI etiology, favoring Type 2 MI based on symptom resolution with transfusion.
• Management involved addressing GI bleeding, attempting dual antiplatelet therapy (DAPT), and subsequent adjustments to monotherapy based on bleeding recurrence.

Main Results:

• The patient's MI etiology was complex, with Type 2 MI suspected.
• Dual antiplatelet therapy (DAPT) was initiated but discontinued due to recurrent GI bleeding.
• Antiplatelet monotherapy was eventually withheld, with conservative management of ischemic heart disease.
• The patient required rehospitalization for recurrent GI bleeding, successfully treated endoscopically.

Conclusions:

• Treating acute ischemic heart disease in patients with high GI bleeding risk requires careful consideration of DAPT.
• Continuous assessment of risks and benefits of DAPT is essential, especially with bleeding.
• Individualized therapy, potentially involving P2Y12 inhibitors like clopidogrel for monotherapy, is supported by this case.
• This case underscores the need for tailored approaches in elderly patients with comorbid coronary artery disease and GI bleeding.